Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hemoglobinopathies × fludarabine phosphate × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Classical hematology 1

Conditions

Thalassemia 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Immunologic Deficiency Syndromes 1 Hemoglobinopathies 1 Hematologic Neoplasms 1 Fanconi Anemia 1 Anemia, Sickle Cell 1

Interventions

fludarabine 2 fludarabine phosphate 1 Thiotepa 1 Melphalan 1 Glucose Tolerance Test 1 Continuous Glucose Monitoring 1 Clofarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01316549 2021-10-04

HCT

University of California, San Francisco

Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡